STOCK TITAN

Milestone Scient Stock Price, News & Analysis

MLSS NYSE

Company Description

Comprehensive Overview

Milestone Scient (MLSS) is a pioneering company in the field of medical technology, specializing in computer-controlled local anesthetic delivery systems. With a commitment to enhancing patient comfort and clinical precision, the company has developed innovative systems that transform traditional injection techniques into a streamlined, virtually painless process. Operating across the dental and medical sectors, MLSS integrates advanced technology with ergonomic design to deliver solutions that cater to a broad spectrum of procedures.

Technology and Innovation

The core of MLSS's success lies in its proprietary technology, which focuses on computer-controlled delivery of local anesthetic agents. By automating the injection process, these systems ensure a controlled, gradual administration of anesthetic, markedly reducing discomfort and anxiety for patients. The technology uses precise algorithms and sensor-driven feedback to tailor the injection speed and pressure, providing a remarkable improvement over traditional manual methods.

Product Applications and Clinical Utility

MLSS's product portfolio is divided into two primary segments: Dental and Medical. In dentistry, the systems are marketed under trademarks that emphasize the technology's capacity for painless procedures, supporting a wide array of dental treatments ranging from routine cleanings and fillings to more complex procedures such as implants, root canals, and crowns. In the medical field, the applications extend to procedures in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, and orthopedics. These systems are engineered to ensure precision and reliability, making them suitable for diverse clinical applications.

Market Position and Global Reach

As an established player in the medical device segment, MLSS has solidified its position through a combination of technological innovation and strategic market penetration. The company’s systems are marketed and sold not only across the United States but also in over 25 countries, underscoring its global presence. MLSS's commitment to research and development and its focus on combining state-of-the-art technology with user-centric design have allowed it to navigate the competitive medtech landscape effectively. The company's ability to address clinical challenges through innovation has resonated with practitioners, helping to foster trust and reliability in its products.

Operational Excellence and Strategic Insights

MLSS operates with a dual-segment strategy focusing on both dental and medical markets, ensuring that its technological advancements impact a wide range of clinical practices. The systems, designed with precision and reliability, offer enhanced control during administration, making them indispensable tools in modern clinical settings. The company's strategic initiatives, including efforts to improve reimbursement strategies and expand its clinical adoption, are reflective of its robust operational framework. Moreover, MLSS maintains an emphasis on continuous innovation and partnerships which further bolster its position within the competitive landscape.

Why MLSS Stands Out

Two defining characteristics set Milestone Scient apart: its commitment to eliminating patient discomfort and its advanced, computer-controlled delivery technology. By converting complex manual procedures into automated precision processes, MLSS significantly reduces the challenges associated with traditional anesthetic administration. The integration of sophisticated control systems and real-time monitoring has not only refined the delivery process but also contributed to more consistent clinical outcomes.

Industry Keywords and Insights

Key industry terms such as computer-controlled injection, local anesthetic delivery, and painless injection technology are integral to understanding the value proposition of MLSS. These terms encapsulate the company’s strategic focus on blending technology with clinical expertise to provide superior, patient-centered solutions.

Conclusion

Milestone Scient represents a significant evolution in the realm of local anesthetic administration. By combining advanced technology with an acute understanding of clinical needs, the company has developed systems that offer both reliability and exceptional patient comfort. With robust global distribution and a comprehensive portfolio that addresses diverse clinical procedures, MLSS continues to set benchmarks in precision, efficiency, and patient care. The detailed approach to technological innovation and product efficacy makes MLSS a critical player in its industry, consistently enhancing the landscape of medical and dental care.

Stock Performance

$0.7800
+7.29%
+0.05
Last updated: June 28, 2025 at 16:31
29.25 %
Performance 1 year
$69.0M
Market Cap
78.5M
Shares outstanding

SEC Filings

Invalid Date

Financial Highlights

$2,513,805
Revenue (TTM)
-$1,461,171
Net Income (TTM)
-$973,914
Operating Cash Flow
-58.13%
Net Profit Margin
-58.44%
Oper. Profit Margin
73.05%
Gross Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Milestone Scient (MLSS)?

The current stock price of Milestone Scient (MLSS) is $0.727 as of June 27, 2025.

What is the market cap of Milestone Scient (MLSS)?

The market cap of Milestone Scient (MLSS) is approximately 69.0M.

What is the revenue (TTM) of Milestone Scient (MLSS) stock?

The trailing twelve months (TTM) revenue of Milestone Scient (MLSS) is $2,513,805.

What is the net income of Milestone Scient (MLSS)?

The trailing twelve months (TTM) net income of Milestone Scient (MLSS) is -$1,461,171.

What is the operating cash flow of Milestone Scient (MLSS)?

The operating cash flow of Milestone Scient (MLSS) is -$973,914.

What is the profit margin of Milestone Scient (MLSS)?

The net profit margin of Milestone Scient (MLSS) is -58.13%.

What is the operating margin of Milestone Scient (MLSS)?

The operating profit margin of Milestone Scient (MLSS) is -58.44%.

What is the gross margin of Milestone Scient (MLSS)?

The gross profit margin of Milestone Scient (MLSS) is 73.05%.

What is the current ratio of Milestone Scient (MLSS)?

The current ratio of Milestone Scient (MLSS) is 2.85, indicating the company's ability to pay short-term obligations.

What is the gross profit of Milestone Scient (MLSS)?

The gross profit of Milestone Scient (MLSS) is $1,836,220 on a trailing twelve months (TTM) basis.

What is the operating income of Milestone Scient (MLSS)?

The operating income of Milestone Scient (MLSS) is -$1,469,179.

What does Milestone Scient specialize in?

Milestone Scient specializes in developing and manufacturing computer-controlled local anesthetic delivery systems for both dental and medical applications. Their systems are designed to provide painless, precise, and controlled delivery of local anesthetic.

How are the company’s products utilized in clinical settings?

The products are used to automate and control the injection of local anesthetics, enhancing patient comfort and clinical precision. They support a range of procedures in dentistry and medicine, from routine treatments to more complex surgeries.

In which markets does Milestone Scient operate?

Milestone Scient operates in both the dental and medical markets, offering solutions that cater to various clinical procedures. Their products are distributed domestically within the United States and internationally in over 25 countries.

What are the technological advantages of the company's systems?

The systems use computer-controlled algorithms and sensor feedback to deliver anesthetic agents in a precise, controlled manner. This technology reduces patient discomfort and improves the accuracy of injections compared to traditional manual techniques.

How does Milestone Scient ensure the efficacy of its delivery systems?

The company invests in continuous research and development to refine its technology. Their systems are rigorously tested and are designed to adapt to various clinical needs while maintaining high levels of precision and reliability.

How does the company differentiate itself from competitors?

MLSS differentiates itself through its proprietary, computer-controlled technology that offers improved patient comfort and clinical efficiency. Its dual-segment approach in dental and medical markets further enhances its competitive edge.

What clinical procedures benefit from the company’s technology?

Both routine dental procedures like cleanings and fillings and complex medical procedures in fields such as plastic surgery, dermatology, and orthopedics benefit from the precision and reliability of MLSS's anesthetic delivery systems.

What drives Milestone Scient's global market presence?

The company’s global presence is driven by its innovative technology, robust operational strategies, and the growing demand for precise, painless anesthetic delivery systems in various clinical settings. Its commitment to quality and strategic partnerships further supports its international expansion.